Pharma Hub and Patient Access Support Service Market, By Service Delivery Type (Standalone Services and Integrated Services), By Payer Type, By Service Type, By Indication, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4871
|
Published Date
March 2026
|
Pages
353
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Pharma Hub and Patient Access Support Service Market size was valued at US$ 3,367.87 Million in 2024, expanding at a CAGR of 7.58% from 2025 to 2032.
The Pharma Hub and Patient Access Support Service market is a specialized ecosystem of outsourced services designed to help pharmaceutical companies streamline patient onboarding, navigate complex reimbursement processes, ensure therapy adherence, and provide ongoing support, particularly for specialty and high-cost medications. Growth is being driven by the increasing complexity of reimbursement frameworks and the rising prevalence of specialty therapeutics, which create pressure on manufacturers to facilitate faster patient access to treatments. A notable trend is the integration of AI-powered patient engagement platforms with digital case management tools, enhancing efficiency and personalization. However, stringent data privacy regulations and fragmented payer systems remain key challenges. At the same time, expanding biologics pipelines and the shift toward value-based care models offer significant opportunities for advanced, outcome-focused patient access solutions globally.
Pharma Hub and Patient Access Support Service Market- Market Dynamics
Pharmaceutical Industry Expansion Fuels Growth in Pharma Hub and Patient Access Support Services Market
The growing demand for pharmaceutical products is expected to drive significant growth in the Pharma Hub and Patient Access Support Service market. As pharmaceutical production, employment, and R&D investments continue to rise, an increasing number of specialty and high-cost therapies are entering the market. This trend has created greater demand for structured patient onboarding, reimbursement support, therapy adherence programs, and financial assistance services. For instance, in 2025, the European Federation of Pharmaceutical Industries and Associations (EFPIA)—a Belgian trade association representing Europe’s research-based pharmaceutical sector—reported that pharmaceutical production in Europe rose from approximately $438.16 billion in 2023 to an estimated $475.2 billion in 2024, alongside increased R&D spending. This industry expansion directly boosts the need for comprehensive patient access and hub support services, ensuring timely therapy initiation and improved patient outcomes.
Pharma Hub and Patient Access Support Service Market- Segmentation Analysis:
The Global Pharma Hub and Patient Access Support Service Market is segmented by Service Delivery Type, Payer Type, Service Type, Indication, and Region.
In 2026, the program enrollment segment is expected to hold the largest market share. Program enrollment involves registering patients in specific initiatives that provide access to healthcare services, medications, and ongoing support for managing their conditions. Rising demand for personalized solutions and the focus on improving patient outcomes are driving the growth of patient enrollment services. Several companies are introducing innovative program enrollment platforms to meet this need. For example, in December 2022, Pfizer Inc. launched Pfizer PAP India, a mobile application designed to facilitate and accelerate enrollment in Pfizer’s Patient Access Programs (PAP). Pfizer operates over ten programs to support patients undergoing treatment, demonstrating the growing emphasis on structured patient onboarding.
Similarly, integrated services are expected to dominate the market in 2026. Pharmaceutical manufacturers increasingly seek comprehensive solutions to streamline services, particularly as complex therapies enter the market and efficient access becomes critical. Integrated platforms unify patient access, reimbursement support, and pharmacy coordination under a single system, addressing the multifaceted challenges of the product lifecycle. For instance, in March 2023, Terebellum (AscellaHealth) expanded its HUB and patient support services for life sciences manufacturers, offering solutions that improve medication access, enhance patient compliance, and optimize outcomes. Terebellum’s outsourced services are widely recognized as best-in-class in the industry.
Pharma Hub and Patient Access Support Service Market- Geographical Insights
In 2026, the Pharma HUB and Patient Access Support Service market in Europe is projected to account for a substantial revenue share. As a developed region, Europe’s higher healthcare spending capacity is driving increased demand for patient access and HUB services. Additionally, the continent’s growing geriatric population is expected to lead to a higher prevalence of chronic and specialty diseases, further boosting the need for structured patient support programs. The United Kingdom is poised for significant market growth over the forecast period, as government initiatives prioritize digital health solutions and investments in research and innovation. These efforts are expected to enhance the role of pharma HUBs and patient access support services in facilitating clinical research, improving therapy access, and optimizing patient outcomes across the region.
Germany Pharma Hub and Patient Access Support Service Market- Country Insights
In 2026, Germany is expected to lead the Pharma HUB and Patient Access Support Service market in Europe. The country is placing increasing emphasis on patient-centered healthcare and clinical research. According to a 2022 report by Cardinal Health, the prior authorization process delays patient care for over 90% of physicians, with approximately 37% of physicians abandoning requests due to the process’s complexity. To improve therapy access and adherence, technology-driven solutions such as electronic Benefit Verification (eBV) and electronic Prior Authorization (ePA) are being adopted to streamline patient onboarding, reduce administrative delays, and ensure timely initiation of treatment.
Pharma Hub and Patient Access Support Service Market- Competitive Landscape:
The Pharma HUB and Patient Access Support Service market is highly competitive, driven by the need to improve patient outcomes, accelerate therapy access, and enhance engagement across complex treatment pathways. Leading service providers differentiate themselves through comprehensive offerings, including reimbursement assistance, financial support programs, patient education platforms, and digital care coordination tools. Strategic partnerships with pharmaceutical manufacturers, payers, and specialty pharmacies are critical to expanding service reach and ensuring seamless care delivery. Companies are also increasingly leveraging data analytics and AI to optimize patient identification, monitor adherence, and track treatment outcomes. Prominent players in this market include Patient Connect, Innomar Strategies, Accredo Health Group (Express Scripts), and McKesson Corporation, each utilizing extensive healthcare networks and integrated support solutions to strengthen their market position.
Recent Developments:
- March 2025: Valeris, one of the largest independent patient access solution providers in the biopharmaceutical sector, was formed through the merger of PharmaCord and Mercalis. The merger combines PharmaCord’s expertise in patient services with Mercalis’ commercialization solutions to enhance patient access, affordability, therapy adherence, and overall healthcare delivery. The organization aims to streamline commercialization processes and improve outcomes for patients and life sciences companies globally.
- June 2023: Labcorp completed the spin-off of Fortrea, which now operates as an independent CRO providing patient access services, Phase I–IV clinical trial management, and technology solutions to biotechnology and pharmaceutical companies worldwide. This strategic move is expected to improve service delivery, unlock shareholder value, and enable targeted, value-creating investments.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- McKesson Corporation
- Valeris (Formerly PharmaCord)
- Cardinal Health
- Envoy Health, Inc
- EVERSANA
- Fortrea
- Mercalis
- Sciensus
- AssistRx
- Lash Group
- Engage
- CareMetx, LLC
- ConnectiveRx.
- NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)
- United BioSource LLC
- Others
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY SERVICE DELIVERY TYPE- MARKET ANALYSIS, 2019 - 2032
- Standalone Services
- Integrated Services
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY PAYER TYPE- MARKET ANALYSIS, 2019 - 2032
- Medicare
- Commercial Insurance
- Self-Pay
- Government Insurance
- Medicaid
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032
- Clinical Educator
- Treatment Navigators
- Process flows and standard operating procedures
- Care team training
- Program literature and scripts
- Systems testing and optimization
- Program Enrolment
- Ease of enrollment (through phone, face, portal, or app)
- Order processing
- Application processing
- Program data
- Reimbursement Services/Affordability Services
- Coordination of Specialty Pharmacy/Dispensing
- Others
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Respiratory Diseases
- Rare Diseases
- Cardiovascular Diseases
- Autoimmune Disorders
- Gastrointestinal Diseases
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Pharma Hub and Patient Access Support Service Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Pharma Hub and Patient Access Support Service Market Snippet by Service Delivery Type
2.1.2. Pharma Hub and Patient Access Support Service Market Snippet by Payer Type
2.1.3. Pharma Hub and Patient Access Support Service Market Snippet by Service Type
2.1.4. Pharma Hub and Patient Access Support Service Market Snippet by Indication
2.1.5. Pharma Hub and Patient Access Support Service Market Snippet by Country
2.1.6. Pharma Hub and Patient Access Support Service Market Snippet by Region
2.2. Competitive Insights
3. Pharma Hub and Patient Access Support Service Key Market Trends
3.1. Pharma Hub and Patient Access Support Service Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Pharma Hub and Patient Access Support Service Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Pharma Hub and Patient Access Support Service Market Opportunities
3.4. Pharma Hub and Patient Access Support Service Market Future Trends
4. Pharma Hub and Patient Access Support Service Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Pharma Hub and Patient Access Support Service Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Pharma Hub and Patient Access Support Service Market Landscape
6.1. Pharma Hub and Patient Access Support Service Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Pharma Hub and Patient Access Support Service Market – By Service Delivery Type
7.1. Overview
7.1.1. Segment Share Analysis, By Service Delivery Type, 2024 & 2032 (%)
7.1.2. Standalone Services
7.1.3. Integrated Services
8. Pharma Hub and Patient Access Support Service Market – By Payer Type
8.1. Overview
8.1.1. Segment Share Analysis, By Payer Type, 2024 & 2032 (%)
8.1.2. Medicare
8.1.3. Commercial Insurance
8.1.4. Self-Pay
8.1.5. Government Insurance
8.1.6. Medicaid
9. Pharma Hub and Patient Access Support Service Market – By Service Type
9.1. Overview
9.1.1. Segment Share Analysis, By Service Type, 2024 & 2032 (%)
9.1.2. Clinical Educator
9.1.3. Treatment Navigators
9.1.3.1. Process flows and standard operating procedures
9.1.3.2. Care team training
9.1.3.3. Program literature and scripts
9.1.3.4. Systems testing and optimization
9.1.4. Program Enrolment
9.1.4.1. Ease of enrollment (through phone, face, portal, or app)
9.1.4.2. Order processing
9.1.4.3. Application processing
9.1.4.4. Program data
9.1.5. Reimbursement Services/Affordability Services
9.1.6. Coordination of Specialty Pharmacy/Dispensing
9.1.7. Others
10. Pharma Hub and Patient Access Support Service Market – By Indication
10.1. Overview
10.1.1. Segment Share Analysis, By Payer Type, 2024 & 2032 (%)
10.1.2. Oncology
10.1.3. Respiratory Diseases
10.1.4. Rare Diseases
10.1.5. Cardiovascular Diseases
10.1.6. Autoimmune Disorders
10.1.7. Gastrointestinal Diseases
11. Pharma Hub and Patient Access Support Service Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Pharma Hub and Patient Access Support Service Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Pharma Hub and Patient Access Support Service Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. McKesson Corporation
12.2.2. Valeris (Formerly PharmaCord)
12.2.3. Cardinal Health
12.2.4. Envoy Health, Inc
12.2.5. EVERSANA
12.2.6. Fortrea
12.2.7. Mercalis
12.2.8. Sciensus
12.2.9. AssistRx
12.2.10. Lash Group
12.2.11. Engage
12.2.12. CareMetx, LLC
12.2.13. ConnectiveRx.
12.2.14. NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)
12.2.15. United BioSource LLC
12.2.16. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- McKesson Corporation
- Valeris (Formerly PharmaCord)
- Cardinal Health
- Envoy Health, Inc
- EVERSANA
- Fortrea
- Mercalis
- Sciensus
- AssistRx
- Lash Group
- Engage
- CareMetx, LLC
- ConnectiveRx.
- NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)
- United BioSource LLC
- Others
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY SERVICE DELIVERY TYPE- MARKET ANALYSIS, 2019 - 2032
- Standalone Services
- Integrated Services
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY PAYER TYPE- MARKET ANALYSIS, 2019 - 2032
- Medicare
- Commercial Insurance
- Self-Pay
- Government Insurance
- Medicaid
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032
- Clinical Educator
- Treatment Navigators
- Process flows and standard operating procedures
- Care team training
- Program literature and scripts
- Systems testing and optimization
- Program Enrolment
- Ease of enrollment (through phone, face, portal, or app)
- Order processing
- Application processing
- Program data
- Reimbursement Services/Affordability Services
- Coordination of Specialty Pharmacy/Dispensing
- Others
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Respiratory Diseases
- Rare Diseases
- Cardiovascular Diseases
- Autoimmune Disorders
- Gastrointestinal Diseases
GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
